No Question Actavis Goes Beyond Cash, FTC's Wright Says
Drug purchasers and manufacturers may be squabbling over whether settlements have to include cash payments to receive antitrust scrutiny under U.S. Supreme Court precedent, but the Federal Trade Commission's Joshua Wright...To view the full article, register now.
Already a subscriber? Click here to view full article